Cargando…

Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies

In 2013, recognizing that Colorectal Cancer (CRC) is the second leading cause of death by cancer worldwide and that it was a neglected disease increasing rapidly in Mexico, the community of researchers at the Biomedicine Research Unit of the Facultad de Estudios Superiores Iztacala from the Universi...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrade-Meza, Antonio, Arias-Romero, Luis E., Armas-López, Leonel, Ávila-Moreno, Federico, Chirino, Yolanda I., Delgado-Buenrostro, Norma L., García-Castillo, Verónica, Gutiérrez-Cirlos, Emma B., Juárez-Avelar, Imelda, Leon-Cabrera, Sonia, Mendoza-Rodríguez, Mónica G., Olguín, Jonadab E., Perez-Lopez, Araceli, Pérez-Plasencia, Carlos, Reyes, José L., Sánchez-Pérez, Yesennia, Terrazas, Luis I., Vaca-Paniagua, Felipe, Villamar-Cruz, Olga, Rodríguez-Sosa, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917340/
https://www.ncbi.nlm.nih.gov/pubmed/36768437
http://dx.doi.org/10.3390/ijms24032115
_version_ 1784886342208978944
author Andrade-Meza, Antonio
Arias-Romero, Luis E.
Armas-López, Leonel
Ávila-Moreno, Federico
Chirino, Yolanda I.
Delgado-Buenrostro, Norma L.
García-Castillo, Verónica
Gutiérrez-Cirlos, Emma B.
Juárez-Avelar, Imelda
Leon-Cabrera, Sonia
Mendoza-Rodríguez, Mónica G.
Olguín, Jonadab E.
Perez-Lopez, Araceli
Pérez-Plasencia, Carlos
Reyes, José L.
Sánchez-Pérez, Yesennia
Terrazas, Luis I.
Vaca-Paniagua, Felipe
Villamar-Cruz, Olga
Rodríguez-Sosa, Miriam
author_facet Andrade-Meza, Antonio
Arias-Romero, Luis E.
Armas-López, Leonel
Ávila-Moreno, Federico
Chirino, Yolanda I.
Delgado-Buenrostro, Norma L.
García-Castillo, Verónica
Gutiérrez-Cirlos, Emma B.
Juárez-Avelar, Imelda
Leon-Cabrera, Sonia
Mendoza-Rodríguez, Mónica G.
Olguín, Jonadab E.
Perez-Lopez, Araceli
Pérez-Plasencia, Carlos
Reyes, José L.
Sánchez-Pérez, Yesennia
Terrazas, Luis I.
Vaca-Paniagua, Felipe
Villamar-Cruz, Olga
Rodríguez-Sosa, Miriam
author_sort Andrade-Meza, Antonio
collection PubMed
description In 2013, recognizing that Colorectal Cancer (CRC) is the second leading cause of death by cancer worldwide and that it was a neglected disease increasing rapidly in Mexico, the community of researchers at the Biomedicine Research Unit of the Facultad de Estudios Superiores Iztacala from the Universidad Nacional Autónoma de México (UNAM) established an intramural consortium that involves a multidisciplinary group of researchers, technicians, and postgraduate students to contribute to the understanding of this pathology in Mexico. This article is about the work developed by the Mexican Colorectal Cancer Research Consortium (MEX-CCRC): how the Consortium was created, its members, and its short- and long-term goals. Moreover, it is a narrative of the accomplishments of this project. Finally, we reflect on possible strategies against CRC in Mexico and contrast all the data presented with another international strategy to prevent and treat CRC. We believe that the Consortium’s characteristics must be maintained to initiate a national strategy, and the reported data could be useful to establish future collaborations with other countries in Latin America and the world.
format Online
Article
Text
id pubmed-9917340
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99173402023-02-11 Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies Andrade-Meza, Antonio Arias-Romero, Luis E. Armas-López, Leonel Ávila-Moreno, Federico Chirino, Yolanda I. Delgado-Buenrostro, Norma L. García-Castillo, Verónica Gutiérrez-Cirlos, Emma B. Juárez-Avelar, Imelda Leon-Cabrera, Sonia Mendoza-Rodríguez, Mónica G. Olguín, Jonadab E. Perez-Lopez, Araceli Pérez-Plasencia, Carlos Reyes, José L. Sánchez-Pérez, Yesennia Terrazas, Luis I. Vaca-Paniagua, Felipe Villamar-Cruz, Olga Rodríguez-Sosa, Miriam Int J Mol Sci Review In 2013, recognizing that Colorectal Cancer (CRC) is the second leading cause of death by cancer worldwide and that it was a neglected disease increasing rapidly in Mexico, the community of researchers at the Biomedicine Research Unit of the Facultad de Estudios Superiores Iztacala from the Universidad Nacional Autónoma de México (UNAM) established an intramural consortium that involves a multidisciplinary group of researchers, technicians, and postgraduate students to contribute to the understanding of this pathology in Mexico. This article is about the work developed by the Mexican Colorectal Cancer Research Consortium (MEX-CCRC): how the Consortium was created, its members, and its short- and long-term goals. Moreover, it is a narrative of the accomplishments of this project. Finally, we reflect on possible strategies against CRC in Mexico and contrast all the data presented with another international strategy to prevent and treat CRC. We believe that the Consortium’s characteristics must be maintained to initiate a national strategy, and the reported data could be useful to establish future collaborations with other countries in Latin America and the world. MDPI 2023-01-20 /pmc/articles/PMC9917340/ /pubmed/36768437 http://dx.doi.org/10.3390/ijms24032115 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Andrade-Meza, Antonio
Arias-Romero, Luis E.
Armas-López, Leonel
Ávila-Moreno, Federico
Chirino, Yolanda I.
Delgado-Buenrostro, Norma L.
García-Castillo, Verónica
Gutiérrez-Cirlos, Emma B.
Juárez-Avelar, Imelda
Leon-Cabrera, Sonia
Mendoza-Rodríguez, Mónica G.
Olguín, Jonadab E.
Perez-Lopez, Araceli
Pérez-Plasencia, Carlos
Reyes, José L.
Sánchez-Pérez, Yesennia
Terrazas, Luis I.
Vaca-Paniagua, Felipe
Villamar-Cruz, Olga
Rodríguez-Sosa, Miriam
Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies
title Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies
title_full Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies
title_fullStr Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies
title_full_unstemmed Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies
title_short Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies
title_sort mexican colorectal cancer research consortium (mex-ccrc): etiology, diagnosis/prognosis, and innovative therapies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917340/
https://www.ncbi.nlm.nih.gov/pubmed/36768437
http://dx.doi.org/10.3390/ijms24032115
work_keys_str_mv AT andrademezaantonio mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT ariasromeroluise mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT armaslopezleonel mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT avilamorenofederico mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT chirinoyolandai mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT delgadobuenrostronormal mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT garciacastilloveronica mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT gutierrezcirlosemmab mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT juarezavelarimelda mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT leoncabrerasonia mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT mendozarodriguezmonicag mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT olguinjonadabe mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT perezlopezaraceli mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT perezplasenciacarlos mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT reyesjosel mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT sanchezperezyesennia mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT terrazasluisi mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT vacapaniaguafelipe mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT villamarcruzolga mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies
AT rodriguezsosamiriam mexicancolorectalcancerresearchconsortiummexccrcetiologydiagnosisprognosisandinnovativetherapies